Evidence map›Paper›PMID 22421935›Full record

ReviewIndian journal of pediatrics2012

Retinoblastoma: an overview.

Anish Ray, Dan S Gombos, Tribhawan S Vats

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in Indian journal of pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Salivary Exosomes in Health and Disease: Future Prospects in the Eye.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
    Article
  9. Article
  10. Update on pathology of retinoblastoma.International journal of ophthalmology · 2018
    Review
  11. Article
  12. The bone marrow metastasis niche in retinoblastoma.Cellular oncology (Dordrecht, Netherlands) · 2015
    Review
  13. Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2014
    Article
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
    Vats, Tribhawan S [added]
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anish RayDepartment of Pediatric Hematology/Oncology, Children's Cancer Hospital, MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 87, Houston, TX 77030, USA. akray@mdanderson.org
Dan S Gombos
Tribhawan S Vats
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinoblastoma, the most common intraocular malignancy of childhood arises due to mutation of the retinoblastoma gene on chromosome 13q14. In the hereditary setting this mutation is present in all germ line cells and can occur as early as during development; however it requires a mandatory second "hit" or mutation of the remaining allele for retinoblastoma to develop. The non-hereditary form arises from spontaneous mutation affecting both alleles in a somatic cell of the retina. The tumor may present with leucocoria or strabismus. The diagnosis is best made by an ophthalmologist who examines the patient under sedation. Although tissue biopsy is not routinely performed, imaging studies like ultrasound and MRI scan can serve as useful adjuncts to help in establishing the diagnosis and also aid in staging. Group A tumors are smaller than 3 mm while group B tumors are >3 mm or those located in the macula. Groups C and D tumors are associated with localized and diffuse vitreous seeds respectively. Group E tumors occupy >50% of the globe and are generally not salvagable. Despite the fact that great advances have been made in the treatment of retinoblastoma in the last two decades, a large number patients undergo procedures associated with significant morbidity such as enucleation. We recommend large multi institutional studies using newer therapeutic models and targeting novel pathways to improve the outcome in advanced stage retinoblastoma.

Indexed as

Retinal NeoplasmsRetinoblastomaAntineoplastic AgentsBrachytherapyCombined Modality TherapyCryotherapyEye EnucleationHumansLaser CoagulationNeoplasm MetastasisNeoplasm StagingStem Cell TransplantationUnited StatesAntineoplastic Agents

Identifiers

PMID22421935
OpenAlexW2012763826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.